Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Oncology

Journal Scan / Research · February 18, 2016

Cola Impacts Absorption of Erlotinib in NSCLC

Journal of Clinical Oncology

 

Additional Info

Disclosure statements are available on the authors' profiles:

Journal of Clinical Oncology
Influence of the Acidic Beverage Cola on the Absorption of Erlotinib in Patients With Non-Small-Cell Lung Cancer
J. Clin. Oncol 2016 Feb 08;[EPub Ahead of Print], RW van Leeuwen, R Peric, KG Hussaarts, E Kienhuis, NS IJzerman, P de Bruijn, C van der Leest, H Codrington, JS Kloover, B van der Holt, JG Aerts, T van Gelder, RH Mathijssen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading